130 results
8-K
TXMD
TherapeuticsMD Inc
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
the initial $140.0 million payment to the Company from cash and existing debt facilities and through a binding commitment from Rubric Capital Management
8-K
EX-10.2
pyj58xrkis85e10ovi22
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
qy1b5d
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
uvsbk0l0hisrmj3
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-10.2
9azzlf7az9i1433n
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-10.1
v7aiy 1mzyk9p
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
8-K
EX-10.2
qphsq4s9ax
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
SC TO-T/A
EX-99
jaz5z14s
6 Jul 22
Third party tender offer statement (amended)
6:23am
SC TO-T/A
sr3t1b
6 Jul 22
Third party tender offer statement (amended)
6:23am
SC 14D9
trrz5g61
10 Jun 22
Tender offer solicitation
6:51pm
SC TO-T
4idkt9il
6 Jun 22
Third party tender offer statement
5:02pm
SC TO-T
EX-99
bozejgs9 z0u7oikc2
6 Jun 22
Third party tender offer statement
5:02pm
SC TO-T
EX-99
wp1vemc
6 Jun 22
Third party tender offer statement
5:02pm
SC TO-T
EX-99
rum5p3itthh4g40qtt
6 Jun 22
Third party tender offer statement
5:02pm